Literature DB >> 23924405

Determination of iriflophenone 3-C-β-d-glucoside from Aquilaria spp. by an indirect competitive enzyme-linked immunosorbent assay using a specific polyclonal antibody.

Waraporn Putalun1, Gorawit Yusakul, Paritad Saensom, Boonchoo Sritularak, Hiroyuki Tanaka.   

Abstract

Polyclonal antibody against iriflophenone 3-C-β-d-glucoside (IP3G), a major compound from the leaves of Aquilaria spp., was produced for the development of an enzyme-linked immunosorbent assay (ELISA). The results showed that the antibodies were specific for IP3G. The produced antibody has low cross reactivity with iriflophenone 3,5-C-β-d-diglucopyranoside (13%), genkwanin 5-O-β-primeveroside (3.55%) and no cross reactivity found in other compounds. The range of ELISA assay extends from 100 to 1560 ng/mL with coefficient of variation (CV) 1.19% to 2.07% for intra-assay and 3.76% to 7.15% for inter-assay precision levels. The recovery rates of IP3G in the leaves of Aquilaria spp. were in the range of 96.0% to 99.0% with CV 4.50% to 5.32%. A correlation between ELISA and high-performance liquid chromatography methods was obtained when analysis of IP3G in the plant samples (R(2) = 0.9321). These results suggest that the developed ELISA method can be applied to determine IP3G content with high specificity, rapidity, and simplicity. The developed immunosorbent assay in this study provides a useful tool for the analysis of IP3G in plant samples and products.
© 2013 Institute of Food Technologists®

Entities:  

Keywords:  ELISA; analysis; chemical composition; diabetes

Mesh:

Substances:

Year:  2013        PMID: 23924405     DOI: 10.1111/1750-3841.12225

Source DB:  PubMed          Journal:  J Food Sci        ISSN: 0022-1147            Impact factor:   3.167


  1 in total

1.  Iriflophenone-3-C-β-d Glucopyranoside from Dryopteris ramosa (Hope) C. Chr. with Promising Future as Natural Antibiotic for Gastrointestinal Tract Infections.

Authors:  Muhammad Ishaque; Yamin Bibi; Samha Al Ayoubi; Saadia Masood; Sobia Nisa; Abdul Qayyum
Journal:  Antibiotics (Basel)       Date:  2021-09-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.